CMAC Welcomes Pfizer as Newest Partner

CMAC announces that Pfizer Inc has joined as a strategic member, alongside GSK, AZ, Novartis, Bayer, Takeda, Lilly and Roche.

Professor Alastair Florence of Strathclyde, Director of the CMAC EPSRC Research Future Manufacturing Research Hub, said: “Pfizer’s interests in continuous manufacturing are aligned with our Hub program, especially our common goal of improving development efficiency and manufacturing through digital design.”

“We are delighted to join CMAC and look forward to working together with other members to advance the pharmaceutical manufacturing process,” said Nick Thomson, Senior Director Technology API at Pfizer.